Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F CODINGTON

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Experientia|March 15, 1985
Effects of retinoic acid on ascites cells of the TA3 mouse mammary carcinomaE Walker-Nasir, J F Codington, L A Lampert, et al.
Journal of the National Cancer Institute|July 1, 1979
Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growthA G Cooper, J F Codington, D K Miller, et al.
The Biochemical Journal|April 1, 1985
Location of an epitopic site on epiglycanin by molecular immunoelectron microscopyJ K Wold, H S Slayter, J F Codington, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycaninT Thingstad, S Haavik, K Hansen, et al.
Carbohydrate Research|April 1, 1980
Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycaninI Matsumoto, J F Codington, M R Jahnke, et al.
Carbohydrate Research|March 1, 1975
Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cellJ F Codington, K B Linsley, R W Jeanloz, et al.
Journal of the National Cancer Institute|August 1, 1982
Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinomaE Walker-Nasir, J F Codington, M R Jahnke, et al.
Journal of the National Cancer Institute|April 1, 1978
Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybridsJ F Codington, G Klein, A G Cooper, et al.
Glycoconjugate Journal|December 22, 1999
Specificity studies of an antibody developed against a mucin-type glycoproteinS Haavik, M Nilsen, T Thingstad, et al.
Journal of the National Cancer Institute|November 1, 1984
Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patientsJ F Codington, V P Bhavanandan, K J Bloch, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Experientia|March 15, 1985
Effects of retinoic acid on ascites cells of the TA3 mouse mammary carcinomaE Walker-Nasir, J F Codington, L A Lampert, et al.
Journal of the National Cancer Institute|July 1, 1979
Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growthA G Cooper, J F Codington, D K Miller, et al.
The Biochemical Journal|April 1, 1985
Location of an epitopic site on epiglycanin by molecular immunoelectron microscopyJ K Wold, H S Slayter, J F Codington, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycaninT Thingstad, S Haavik, K Hansen, et al.
Carbohydrate Research|April 1, 1980
Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycaninI Matsumoto, J F Codington, M R Jahnke, et al.
Carbohydrate Research|March 1, 1975
Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cellJ F Codington, K B Linsley, R W Jeanloz, et al.
Journal of the National Cancer Institute|August 1, 1982
Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinomaE Walker-Nasir, J F Codington, M R Jahnke, et al.
Journal of the National Cancer Institute|April 1, 1978
Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybridsJ F Codington, G Klein, A G Cooper, et al.
Glycoconjugate Journal|December 22, 1999
Specificity studies of an antibody developed against a mucin-type glycoproteinS Haavik, M Nilsen, T Thingstad, et al.
Journal of the National Cancer Institute|November 1, 1984
Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patientsJ F Codington, V P Bhavanandan, K J Bloch, et al.
Pageof 3